Lotus Pharmaceutical September Revenue Rises to NT$2.77B
Lotus Pharmaceutical reported September revenue of NT$2,766,433,000, compared with NT$1,213,533,000 a year earlier. Jan-Sep revenue was NT$24,818,419,000 versus NT$14,247,508,000.
Lotus Pharmaceutical Co. Ltd. reported revenue of NT$2,766,433,000 for 2026, compared with NT$1,213,533,000 in 2025. Revenue for Jan-Sep was NT$24,818,419,000, versus NT$14,247,508,000 in the same period of 2025.
Source: Taiwan Stock Exchange.